Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model

• Sylvia Wagner,

  Affiliation Department of Cell Biology and Applied Virology, Fraunhofer Institute for Biomedical Engineering, Sankt Ingbert, Germany

  ⨯
• Jürgen Kufleitner,

  Affiliation Institute of Pharmaceutical Technology, Goethe-University, Frankfurt am Main, Germany

  ⨯
• Anja Zensi,

  Affiliation Institute of Pharmaceutical Technology, Goethe-University, Frankfurt am Main, Germany

  ⨯
• Miriam Dadparvar,

  Affiliation Institute of Pharmaceutical Technology, Goethe-University, Frankfurt am Main, Germany

  ⨯
• Sascha Wien,

  Affiliation Department of Cell Biology and Applied Virology, Fraunhofer Institute for Biomedical Engineering, Sankt Ingbert, Germany

  ⨯
• Judith Bungert,

  Affiliation Department of Cell Biology and Applied Virology, Fraunhofer Institute for Biomedical Engineering, Sankt Ingbert, Germany

  ⨯
• Tikva Vogel,

  Affiliation Biotechnology General, Rehovot, Israel

  ⨯
• Franz Worek,

  Affiliation Bundeswehr Institute of Pharmacology und Toxicology, München, Germany

  ⨯
• Jörg Kreuter,

  Affiliation Institute of Pharmaceutical Technology, Goethe-University, Frankfurt am Main, Germany

  ⨯
• Hagen von Briesen

  * E-mail: hagen.briesen@ibmt.fraunhofer.de

  Affiliation Department of Cell Biology and Applied Virology, Fraunhofer Institute for Biomedical Engineering, Sankt Ingbert, Germany

  ⨯